Page last updated: 2024-08-21

chenodeoxycholic acid and Astrocytoma, Grade IV

chenodeoxycholic acid has been researched along with Astrocytoma, Grade IV in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazin, MA; Clément, M; Descamps, G; El Kihel, L; Khalid, M; Rault, S1
Brossard, D; Clément, M; El Kihel, L; Khalid, M; Rault, S; Roussakis, C; Sebbahi, W1
Baek, SJ; Kim, JH; Kim, JY; Kim, ND; Kim, YC; Lee, SH; Lim, YJ; Park, BS; Seo, SY; Suh, H; Yee, SB; Yeo, WJ; Yoo, YH1

Other Studies

3 other study(ies) available for chenodeoxycholic acid and Astrocytoma, Grade IV

ArticleYear
New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines.
    Bioorganic & medicinal chemistry, 2008, Sep-15, Volume: 16, Issue:18

    Topics: Amides; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Colonic Neoplasms; DNA Fragmentation; Glioblastoma; Humans; Lithocholic Acid; Multiple Myeloma; Neoplasms; NF-kappa B; Piperazines; Signal Transduction

2008
Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:7

    Topics: Apoptosis; Bile Acids and Salts; Cell Line, Tumor; Colonic Neoplasms; Glioblastoma; Humans; Multiple Myeloma; Piperazine; Piperazines

2010
Synthetic chenodeoxycholic acid derivatives inhibit glioblastoma multiform tumor growth in vitro and in vivo.
    International journal of oncology, 2005, Volume: 27, Issue:3

    Topics: Animals; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 3; Caspases; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chenodeoxycholic Acid; DNA Fragmentation; Enzyme Activation; Glioblastoma; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Poly(ADP-ribose) Polymerases; Survival Analysis; Time Factors; Xenograft Model Antitumor Assays

2005